Rationale: Nuclear factor erythroid 2-related factor (Nrf)3, a member of the cap 'N' collar family of transcription factors that bind to the DNA-antioxidant responsive elements, is involved in reactive oxygen species balancing and in muscle precursor migration during early embryo development. Objective: To investigate the functional role of Nrf3 in smooth muscle cell (SMC) differentiation in vitro and in vivo. Methods and Results: Nrf3 was upregulated significantly following 1 to 8 days of SMC differentiation. Knockdown of Nrf3 resulted in downregulation of smooth muscle specific markers expression, whereas enforced expression of Nrf3 enhanced SMC differentiation in a dose-dependent manner. SMC-specific transcription factor myocardin, but not serum response factor, was significantly upregulated by Nrf3 overexpression. Strikingly, the binding of SRF and myocardin to the promoter of smooth muscle differentiation genes was dramatically increased by Nrf3 overexpression, and Nrf3 can directly bind to the promoters of SMC differentiation genes as demonstrated by chromatin immunoprecipitation assay. Moreover, NADPH-derived reactive oxygen species production during SMC differentiation was further enhanced by Nrf3 overexpression through upregulation of NADPH oxidase and inhibition of antioxidant signaling pathway. In addition, Nrf3 was involved in the endoplasmic reticulum stressor induced SMC differentiation. Conclusion: Our findings demonstrate for the first time that Nrf3 has a crucial role in SMC differentiation from stem cells indicating that Nrf3 could be a potential target for manipulation of stem cell differentiation toward vascular lineage. (Circ Res. 2010;106:870-879.)
cific cell lineages via intermediate progenitors or precursors. Two such precursors, Flk-1-and Sca-1-positive cells derived from mouse ESCs, act in vitro as common vascular progenitors and differentiate toward endothelial cells or smooth muscle cells (SMCs). [1] [2] [3] Our previous studies showed that growth factor stimulation, 2 mechanical force or extracellular matrix 4 can be used to drive ESC differentiation toward the vascular lineage. We have established an in vitro model for ESC differentiation into SMCs, 3 which involves the choice of extracellular matrix protein collagen IV, 3, 5, 6 to investigate SMC differentiation more closely. In the adult organism, SMCs have the main physiological function of contracting and controlling the blood vessel tone, diameter, blood pressure and blood flow. In response to vascular injury, SMCs dramatically increase their rate of proliferation, migration and synthetic capacity. 7, 8 Atherosclerosis and postangioplasty restenosis, for example, are characterized by the development of an enlarged neointima. 9 The cells responsible for the neointima formation have been identified as not only SMC migrating from the tunica media, 10 but also vascular progenitors that originate from the circulation and the perivascular adventitia, which differentiate into vascular SMCs in the lesion. [11] [12] [13] [14] However, the mechanisms involved in SMC differentiation in vitro and in vivo is still poorly understood.
In a microarray screen for factors involved in vascular progenitor differentiation, we identified nuclear factor erythroid 2-related factor (Nrf)3 expression to be constantly modulated. Nrf3 is the most recently identified member of the Nrf family and contains a domain homologous to the cap 'N' collar (CNC) transcription factors. 15 The CNC domain is a unique, conserved region, located at the amino-terminus of the bZIP domain. 16 Nrf3 heterodimerizes with MafK and MafG and this complex binds to the ␤-globin enhancer. 17, 18 Nrf3 is able to represses antioxidant responsive elementmediated gene expression of antioxidant enzymes, such as the NAD(P)H:quinone oxidoreductase1 (NQO1) 19 and peroxiredoxin 6. 20 Recently we have shown that reactive oxygen species (ROS) are also involved in ESC differentiation toward SMCs. 21, 22 During embryonic development, Nrf3 is associated with mesodermal segment determination. 23 As the myotome differentiates, Nrf3 expression is downregulated but not abrogated. However, the details regarding Nrf3 function during early embryonic development and muscle differentiation in vitro and in vivo remain to be elucidated. In the present study, we provide novel information on the role of Nrf3 in driving ESC differentiation toward the SMC lineage and activation of the serum response factor (SRF)-myocardin complex. We also demonstrate that Nrf3 is an important regulator of the ROS balance in differentiating ESCs, and is therefore a crucial new target for influencing stem cell fate.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
ESC Culture and SMC Differentiation
Mouse embryonic stem cells (ESCs), line ES-D3 cell line, CRL-1934 (American Type Culture Collection, Manassas, Va) were maintained as described previously. 2 To induce differentiation, ESCs were plated on collagen IV (5 g/mL) coated plates and cultured in differentiation medium: ␣-MEM (Gibco) supplemented with 10% FBS, 50 mol/L of 2-mercaptoethanol and 100 g/mL penicillin/ streptomycin. In some specific experiments, cells were treated with actinomycin D in DMSO (1 g/mL) for 6 hours, and different concentrations of thapsigargin in DMSO (0.1, 0.2, 0.4 mol/L) for 24 hours before harvesting, respectively.
Small Interfering RNA Knockdown
The Nrf3 small interfering small interfering (si)RNA (ID 156503; forward: 5Ј-GGCACAAGAACCAUUUCUGTT-3Ј; reverse: 5Ј-CAGAAAUGGUUCUUGUGCCTG-3Ј) and the negative control siRNA (Negative Control #3 AM4615; forward: 5Ј-GGAACU-UCGUCAUCCAAAUTT-3Ј; reverse: 5Ј-AUUUGGAUGACGAA-GUUCCTT-3Ј) were purchased from Ambion Ltd (Huntingdon, UK). Mouse ESCs were seeded on Collagen IV and cultured in differentiation medium. Twenty-four hours after plating 10 L of 10 mol/L siRNA were introduced with siIMPORTER transfection reagent (Millipore) according to the instructions of the manufacturer. Cells were harvested at 48 or 72 hours after transfection, and real-time RT-PCR and Western blot analysis were performed to analyze mRNA and protein levels, respectively.
Transient Transfection
Nrf3 overexpression plasmid pef-BOS-Nrf3 was prepared as described previously. 15 Differentiating ESCs were cultured on collagen IV and transfected at a 60% confluence at day 1 with Nrf3 expression plasmid (pef-BOS-Nrf3) or empty vector (pef-BOS) with Fugene-6 (Roche Molecular Biochemicals, Indianapolis, Ind) according to the instructions of the manufacturer. The reporter plasmids PGL3-SM␣A-Luc and PGL3-SM22␣-Luc used in the luciferase assay were previously designed and generated in our laboratory. 6 For these experiments, ESCs were cultured on collagen IV-coated 12-well plate for 3 days and then cotransfected with reporter gene (0.33 g/5ϫ10 4 cells) and Nrf3 expression plasmid or empty vector (0.16 g/5ϫ10 4 cells), using Fugene-6-Reagent (Roche Molecular Biochemicals), according to the instructions of the manufacturer. 
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Lucigenin-Enhanced Chemiluminescence Assay
The lucigenin-enhanced chemiluminescence assay was performed to measure NADPH oxidase activity in undifferentiated and differentiating ESCs. The procedure used for this assay was similar to that described previously. 21 The enzymatic source of NADPH-stimulated superoxide production in undifferentiated and differentiating ESCs was determined using the following inhibitors: diphenylene iodonium (inhibits all flavoproteins [10 mol/L]), nitro-L-arginine methyl ester (L-NAME) ( 
Chromatin Immunoprecipitation
The chromatin immunoprecipitation (ChIP) assays were performed as described previously. 5 The primers used to amplify the promoter regions were (SM22␣ forward: GGATTTGGGGAATCCTGTCT; SM22␣ reverse: GGGAAGGAGAGAACCCTCAG; SM␣A forward: GGC AAC ACA GGC TGG TTA AT; SM␣A reverse: AGC CCC TGT CTG GCT AGT CT).
Results
Nrf3 Is Upregulated During SMC Differentiation
To determine whether Nrf3 was involved in SMC development, total RNA and protein were harvested and subjected to real-time RT-PCR and Western blot analysis, respectively, to assess Nrf3 expression at days 0, 4, 6, and 8 of SMC differentiation ( Figure 1A and 1B). As shown in Figure 1A and 1B, Nrf3 expression was transiently upregulated during SMC differentiation, peaked at day 4 and displayed a sustained signal until day 8. Nrf3 expression preceded SMC marker induction, which commenced at day 4 and then progressively increased during the following days of culture on collagen IV. Double immunostaining against Nrf3 and SM␣A ( Figure 1C ) showed that Nrf3 localized in the nucleus at early stage (day 4), but colocalized with SM␣A at the late stage (day6) of SMC differentiation.
Nrf3 Is Essential for SMC Differentiation
Enforced expression of Nrf3 significantly upregulated SMCspecific marker expression, such as SM␣A, SM22␣, h1calponin, and smooth muscle myosin heavy chain (SM-myh11), in a dose dependent manner, both at mRNA levels and protein levels (Figure 2A and 2B). These data indicate that Nrf3 is able to enhance ESC differentiation toward the SMC lineage. To determine whether Nrf3 overexpression specifically induced SMC differentiation, the expression of other cell lineage specific genes was evaluated by real-time RT-PCR. These genes were chosen based on our previous microarray analysis 21 as they displayed upregulation during ES cell differentiation on collagen IV. Apart from two markers, ␣-cardiac actin and CD133, no other genes were influenced by Nrf3 overexpression (Online Figure I) , indicating that Nrf3 was, to some extent specific for smooth muscle differentiation under our culture conditions. To further investigate if Nrf3 expression was necessary for smooth muscle marker expression, siRNA knockdown experiments were performed in differentiating ESCs using Nrf3 or control siRNA. Our data revealed that the collagen IV-induced upregulation of smooth muscle markers was inhibited by Nrf3 specific siRNA ( Figure 2C ), indicating that Nrf3 expression was essential.
Nrf3 Upregulates the SMC Transcription Factor Myocardin
Several transcription factors are activated during SMC development, including SRF and its cofactor myocardin which is exclusively expressed in SMCs and cardiomyocytes. 24 Importantly, both SRF and myocardin, like Nrf3, are significantly upregulated in our SMC differentiation system, 21 alongside Nrf3. Therefore, we decided to investigate if these factors worked in concert. Overexpression of Nrf3 upregulated myocardin ( Figure 3A and 3B) but had no significant effect on SRF expression. To further elucidate the mechanism involved in the interaction between Nrf3 and myocardin, RNA synthesis inhibitor actinomycin D (1 g/mL, for 6 hours) was applied in the Nrf3 overexpression experiments in differentiating ESCs. Inhibition of new RNA synthesis abrogates the enhancing effect of Nrf3 overexpression on myocardin gene expression ( Figure 3C ), suggesting that Nrf3 regulates myocardin gene expression at the transcriptional level.
Nrf3 Regulates SMC Genes Expression Through Transcriptional Activation
To further clarify how Nrf3 regulates SMC gene expression, differentiating ESCs were transfected with pef-BOS-Nrf3, treated with actinomycin D (1 g/mL for 6 hours) and analyzed by real time RT-PCR. Actinomycin D ablated the effect of Nrf3 overexpression on the gene expression levels of SM␣A ( Figure 4A ). To further elucidate the possibility that Nrf3 regulates the SMC markers at the transcriptional level, luciferase gene reporter assay were performed. Our data revealed that Nrf3 overexpression significantly increased SM␣A reporter activity (Fig- ure 4B), indicating that Nrf3 directly activates SMCspecific genes at transcriptional level. To test whether Nrf3 overexpression affected the recruitment of SRF and myocardin to SMC gene promoter regions, ChIP assays were performed with SRF and myocardin specific antibodies ( Figure 4C and 4D ). Nrf3 overexpression significantly increased myocardin binding to the SM␣A and SM22␣ promoters ( Figure 4C ) and the binding of SRF to the SM␣A promoter ( Figure 4C ). Importantly, ChIP assays using an Nrf3 specific antibody further revealed that Nrf3 directly binds to the promoter regions of SM␣A and SM22␣ ( Figure  4D) , and its binding can be enhanced dramatically by Nrf3 overexpression. These findings demonstrate for the first time that Nrf3 regulates SM␣A and SM22␣ gene expression during SMC differentiation by increasing the recruitment of the myocardin/SRF complex and by direct binding of Nrf3, to the CArG box within the promoter region of SMC-specific genes.
Nrf3 Enhances ROS Production Through Activation of Nox4 and Inhibition of Antioxidant Gene Expression
Nrf3 is a member of the CNC family of transcription factors that bind to antioxidant response elements 19 and consequently are involved in ROS balancing. To clarify whether Nrf3 was involved in such a process in our SMC differentiation model, differentiating ESCs were transfected at day 1 with increasing doses of the pef-BOS-Nrf3 (1, 3, 6 g/10 6 ) or with empty pef-BOS vector as a control. After 48 hours, NADPH oxidase activity and the formation of superoxide were assessed using the lucigenin-enhanced chemiluminescence assay. As expected, NADPH-derived superoxide production was significantly increased by overexpression of Nrf3 ( Figure 5A ). To identify the superoxide source, various inhibitors of superoxide producing enzymes were applied in our study. As shown in Figure 5B , superoxide production was attenuated by flavoproteinsspecific inhibitor diphenylene iodonium and superoxide scavenger-Tiron, but was not significantly affected by other inhibitors, such as mitochondrial respiratory chain complex II (TTFA) and xanthine oxidase inhibitor (Allopurinol) or mitochondrial respiratory chain complex I inhibitor (Rotenone). Superoxide production mediated by Nrf3 overexpression was partially inhibited by NO synthase inhibitor (L-NAME), which suggested that both Nox and Nos are involved in Nrf3 mediating ROS production.
The NADPH oxidase isoform Nox4 (NADPH oxidase homolog 4) is crucial for SMC differentiation, 21 therefore we further investigated the effect of Nrf3 on Nox4 gene expression Nrf3 overexpression provoked a dose dependent increase in Nox4 gene expression ( Figure 5C ) while concomitantly inducing a significant downregulation of various antioxidants, such as Nrf2, NQO1 and peroxiredoxin 6 ( Figure 5D ). Taken together, these results indicate that Nrf3 enhances ROS production in SMC differentiation via Nox4 and the repression of antioxidant genes.
Nrf3 Is Involved in Endoplasmic Reticulum
Stress-Inducer-Mediated SMC Differentiation
Nrf3 is an N-glycosylated protein associated with the endoplasmic reticulum (ER) and the nuclear membrane 25, 26 ; therefore, we performed double-immunostaining with antibodies against Nrf3 and the ER marker PDI, to investigate if Nrf3 is targeted to the ER in our system. As expected, Nrf3 colocalized with PDI in the ER, both at the ESC stage and during SMC differentiation ( Figure 6A ). Interestingly, we also observed some Nrf3 protein translocated into the nucleus during the early stage ( Figure 1C ) of differentiation, but almost all of Nrf3 colocalized with ER and/or SM␣A filaments again at later stages (day 6) ( Figures 6A and 1C) . Additionally, treating day 2 differentiating ESCs with increasing concentrations of ER stress inducer thapsigargin, resulted in a dose dependent upregulation of Nrf3 and SMC markers ( Figure 6B ). To assess Nrf3 dependence on thapsigargin to induce SMC differen-tiation, differentiating ESCs were treated with thapsigargin following knocked-down of Nrf3 expression using siRNA. Scrambled siRNA was used as a negative control. Ablation of Nrf3 expression through siRNA represses thapsigargin induced SMC differentiation, suggesting that thapsigargin may act through Nrf3 ( Figure 6C ).
Discussion
SMC differentiation is a complicated process involving several transcription factors and signal transducers such as SRF, myocardin, MEF2, integrins, 3 Nox4 21 and HDAC7. 6 Our findings have demonstrated that Nrf3 also plays a key role in SMC differentiation from ESCs. Nrf3 is upregulated during SMC differentiation, and its overexpression enhances, whereas knockdown inhibits, SMC differentiation. Nrf3 increases the recruitment of SRF and myocardin, and also directly binds to the promoter of SMC genes. Moreover, Nrf3 is also involved in ROS generation which is an important mediator of SMC differentiation via regulation of Nox4 activation and antioxidant gene expression, and an important molecular linker between ER stress and SMC differentiation. Taken together, our findings provide the first evidence that Nrf3 has a crucial role in SMC differentiation in vitro (Figure 7) . Nrf3 is the most recently identified member of the CNC family of transcription factors 15 whose physiological and/or pathological functions are not fully clarified. We found that Nrf3 is expressed in ESCs, and its expression increases during SMC differentiation. Interestingly, Nrf3 expression precedes SMC marker expression, suggesting that activation of Nrf3 is required for collagen IV-induced SMC differentiation. The localization of Nrf3 also alters during the progression of SMC differentiation from ESCs. Previously, Nrf3 was normally shown to be an ER-nuclear membrane associated protein, 25, 26 which is further confirmed by our study ( Figure 6A ). However, we also observed that Nrf3 localizes in the nucleus of some differentiating cells at day 4 and colocalizes with SM␣A at day 6 of differentiation. We thus speculate that Nrf3 is normally retained in the ER and nuclear membrane, however during early stage of SMC differentiation (day 4), some Nrf3 protein translocates to the nucleus to induce SMC marker gene expression. This may be attributable to various stimuli, including differentiating ESC autosecreted TGF-␤ and PDGF-BB, 21 in addition to integrin signal transduction activation. 3 Following smooth muscle actin filament formation, Nrf3 relocalizes to ER-nuclear membrane and SM␣A within the cytoplasm, in a potential negative feedback mechanism.
ER stress is involved in ESC differentiation toward a multitude of distinct cell lineages such as erythroid, adipose, chondrogenic and osteogenic lineages. [27] [28] [29] [30] [31] In particular, during myogenesis ER stress enhances myoblast differentiation and myofiber formation. 32 Cho et al 31 have shown that ER stress increases during ESC differentiation toward neural cells and that this differentiation is further enhanced through chemical treatment with the ER stress inducers, thapsigargin and tunicamycin. We demonstrated that Nrf3 localizes to the ER at different stages of differentiation ( Figure 6A ) and Zhang et al 26 have demonstrated that ER chemical stressors in COS-1 cells activate Nrf3. We therefore hypothesized that ER stress could also affect Nrf3 in our system to initiate SMC differentiation. Our data showed that thapsigargin treatment increases the expression of Nrf3 and SMC markers SM␣A and SM-myh11, and this increase is blocked by Nrf3 knockdown. However, another ER inducer, tunicamycin, had no effect on SMC differentiation or Nrf3 activity (data not shown), which seems to conflict with previous report. 26 Zhang et al reported that tunicamycin, but not thapsigargin, has effect on Nrf3 activation in Cos-1 cells. Such difference might simply be attributable to the different cell systems used in these studies. Additionally, the two ER stress inducers have a different mechanism of action: whereas thapsigargin acts by blocking the ability of the cell to pump calcium into the sarcoplasmic and endoplasmic reticula, tunicamycin blocks the synthesis of all N-linked glycoproteins. 33 Following ER stress, increased ROS generation was observed in our differentiation system. We found that Nrf3 is acts as a pro-oxidant gene. Nrf3 overexpression enhances NADPH-stimulated superoxide production and increases the levels of Nox4, while concomitantly downregulating the levels of the antioxidant genes NQO1, peroxiredoxin 6 and Nrf2. ROS are now recognized as important secondary messengers during cell signaling processes 34, 35 and are also involved in ESC differentiation toward SMCs. 21, 22 In this study we showed that Nrf3 overexpression further enhanced the NADPH-derived superoxide production during differentiation, and that the use of NO synthase inhibitor L-NAME also provoked a significant inhibition of the Nrf3-mediated superoxide production, although the inhibition was less significant than that obtained with dpi and tiron. These results suggest that the enhanced superoxide production attributable to Nrf3 overexpression is from both the NADPH oxidase and NO synthase. A possible explanation for the increased superoxide production from the NADPH oxidase source comes from the observation that overexpression of Nrf3 increases the levels of Nox4, whereas the downregulation of the antioxidants by Nrf3 could result in the mixed contribution of superoxide from other sources. Thus, ROS level regulation by Nrf3 is important in cell differentiation.
Previously we demonstrated that basal ROS generation is essential for stem cell differentiation into SMCs, in which ROS activates transcription factors. 21 Further investigation into the mechanisms of Nrf3-mediated SMC differentiation demonstrates that overexpression of Nrf3 increases the activity of the SM␣A promoter and that this increase is ablated by the RNA synthase inhibitor actinomycin D. These results suggest that Nrf3 activates SMC genes at the transcriptional level. Overexpression of Nrf3 increases the expression of the transcription factor myocardin and also promotes the binding of SRF and myocardin to the promoter regions of SM␣A and SM22␣ as shown by ChIP experiments. We speculate that Nrf3 enhances the ability of SRF and myocardin to bind to the SMC-specific promoters through increasing the levels of myocardin. The mechanism through which Nrf3 upregulates myocardin is still unclear and subject to further investigation. However, our initial data indicate that inhibition of transcription prevents the Nrf3 induced upregulation of myocardin, suggesting that this is a transcriptionally regulated event. myocardin is a SMC-specific SRF coactivator that interacts with SRF through a basic and glutamine-rich domain near the N-terminus. 24 This domain increases the association of SRF with methylated histone and CArG box chromatin during activation of SMC gene expression. 36 The elevated levels of myocardin induced by Nrf3 overexpression may lead to an increase in SRF-myocardin complex formation and to enhanced SMC differentiation.
Interestingly, the fact that the levels of myocardin, but not SRF, are influenced by Nrf3 overexpression supports the fact that myocardin is the SRF specific cofactor which is essential for SMC differentiation. 37 Indeed, SRF can regulate two different processes through interaction with different cofactors; SMC proliferation is promoted through interaction with activated early response genes such as Src, whereas SMC differentiation is enhanced through recruiting SMC-specific coactivators such as myocardin. 38 Therefore, the levels of myocardin are critical for regulating SMC differentiation. As we have previously shown, 21 that the SRF/myocardin complex is important for SMC differentiation from stem cells, we would speculate that silencing of myocardin and/or SRF would provoke inhibition of SMC differentiation from stem cells. Indeed, accumulating evidence supports this hypothesis. Perot et al 39 have shown that myocardin inactivation by siRNA in a human leiomyosarcomas cell line leads to a dramatic decrease of smooth muscle differentiation and migration. Moreover, Long et at 40 showed that myocardin is a bifunctional switch for smooth versus skeletal muscle differentiation, inhibiting skeletal muscle differentiation Figure 7 . Nrf3 is crucial for ESC differentiation toward SMCs. During the early phases of ESC differentiation, Nrf3 translocates from the ER to the nucleus, which in turn activates SRF/myocardin complex formation and also directly binds to the promoter region of SMC-specific genes. Nrf3 also regulates superoxide production through elevating the levels of Nox4 and downregulating the expression of antioxidant enzymes. The increased ROS production is itself able to enhance SMC differentiation. At a later stage of differentiation, the SM␣A filaments have formed and Nrf3 is recruited back to the cytoskeleton and the ER. while activating SMC-specific genes. Finally, Jeon et al 41 have shown that siRNA-mediated depletion of SRF and/or myocardin abolished SMC differentiation from mesenchymal stem cell because of failure to form SRF/myocardin complex. Therefore we believe Nrf3 mediated upregulation of myocardin may play a crucial role in SMC differentiation from ESCs. Importantly, our ChIP assay data also revealed that Nrf3 binds to some regions of the SM␣A and SM22␣ gene promoter ( Figure 4D ). It is reported that Nrf3 binds to antioxidant response element. 19 However, there are no concensus antioxidant response element binding sites present in the SM␣A and SM22␣ promoter regions, suggesting that Nrf3 may also bind to other element/s yet to be identified. The ChIP assay showed that Nrf3 binds to the same region of DNA as SRF and myocardin, though we cannot conclude whether it is the same site. To define the exact binding site, additional in vitro binding assays, deletion constructs and mutational analysis of SMCspecific gene promoters will be required and are under further investigation.
In summary, Nrf3 is crucial for ESC differentiation toward SMCs by altering various conditions in the cell. Initially Nrf3, which is normally located in the ER, translocates to the nucleus during differentiation. Nrf3 translocation activates SRF/myocardin complex formation and also directly binds to the promoter region of SMC-specific genes. Additionally, Nrf3 increases superoxide production by increasing Nox4 levels and downregulating the expression of antioxidant enzymes. ROS production is in itself able to enhance SMC differentiation. Once the initial stages of differentiation have been accomplished and the SM␣A filaments have formed, Nrf3 relocalizes to the ER and recruited to the SM␣A filaments from the nucleus. Therefore, Nrf3 could be considered as a potential target influencing SMC differentiation from stem cells.
